Guardant Short Term Investments vs Net Receivables Analysis
GH Stock | USD 17.35 0.19 1.11% |
Guardant Health financial indicator trend analysis is much more than just examining Guardant Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Guardant Health is a good investment. Please check the relationship between Guardant Health Short Term Investments and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Short Term Investments vs Net Receivables
Short Term Investments vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Guardant Health Short Term Investments account and Net Receivables. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Guardant Health's Short Term Investments and Net Receivables is 0.58. Overlapping area represents the amount of variation of Short Term Investments that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Guardant Health, assuming nothing else is changed. The correlation between historical values of Guardant Health's Short Term Investments and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Investments of Guardant Health are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Short Term Investments i.e., Guardant Health's Short Term Investments and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.58 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Short Term Investments
Short Term Investments is an item under the current assets section of Guardant Health balance sheet. It contains any investments Guardant Health undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Guardant Health can easily liquidate in the marketplace.Net Receivables
Most indicators from Guardant Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Tax Provision is increasing as compared to previous years. The Guardant Health's current Issuance Of Capital Stock is estimated to increase to about 517.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 250.7M | 293.2M | 336.9M | 177.0M | Total Revenue | 373.7M | 449.5M | 563.9M | 282.4M |
Guardant Health fundamental ratios Correlations
Click cells to compare fundamentals
Guardant Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Guardant Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 962.5M | 2.3B | 2.2B | 1.6B | 1.8B | 1.4B | |
Short Long Term Debt Total | 33.3M | 847.9M | 1.4B | 1.4B | 1.4B | 685.2M | |
Other Current Liab | 37.1M | 44.3M | 152.9M | (21.9M) | 108.3M | 113.7M | |
Total Current Liabilities | 72.7M | 66.8M | 194.7M | 193.2M | 205.9M | 112.0M | |
Total Stockholder Equity | 798.4M | 1.3B | 645.0M | 60.2M | 158.7M | 150.7M | |
Other Liab | 8.6M | 1.5M | 3.9M | 9.2M | 8.3M | 6.7M | |
Net Tangible Assets | 779.7M | 1.3B | 627.5M | 45.2M | 51.9M | 49.3M | |
Property Plant And Equipment Net | 72.8M | 100.1M | 313.9M | 341.9M | 302.7M | 163.8M | |
Current Deferred Revenue | 12.3M | 8.6M | 11.3M | 17.4M | 18.0M | 12.2M | |
Net Debt | (110.0M) | 14.9M | 868.7M | 1.2B | 220.2M | 274.0M | |
Retained Earnings | (352.8M) | (606.6M) | (1.0B) | (1.7B) | (2.1B) | (2.0B) | |
Accounts Payable | 16.2M | 7.3M | 17.6M | 175.8M | 51.7M | 39.5M | |
Cash | 143.2M | 833.0M | 492.2M | 141.6M | 1.1B | 1.2B | |
Non Current Assets Total | 365.2M | 383.4M | 1.1B | 418.4M | 439.3M | 402.7M | |
Non Currrent Assets Other | 4.9M | 17.2M | 60.9M | 61.5M | 124.2M | 130.4M | |
Other Assets | 4.9M | 17.2M | 60.9M | 36.5M | 41.9M | 44.0M | |
Cash And Short Term Investments | 522.8M | 1.8B | 932.7M | 1.0B | 1.2B | 847.8M | |
Net Receivables | 48.0M | 53.3M | 97.7M | 97.3M | 88.8M | 60.1M | |
Common Stock Shares Outstanding | 90.6M | 97.5M | 101.3M | 102.2M | 112.0M | 92.9M | |
Short Term Investments | 379.6M | 961.9M | 440.5M | 869.6M | 35.1M | 33.3M | |
Liabilities And Stockholders Equity | 962.5M | 2.3B | 2.2B | 1.6B | 1.8B | 1.4B | |
Non Current Liabilities Total | 41.8M | 849.4M | 1.4B | 1.4B | 1.4B | 1.5B | |
Capital Surpluse | 1.2B | 1.9B | 1.7B | 1.7B | 2.0B | 1.1B | |
Capital Lease Obligations | 40.4M | 41.6M | 226.1M | 231.9M | 213.8M | 224.5M | |
Inventory | 15.2M | 22.7M | 30.7M | 51.6M | 61.9M | 65.0M | |
Other Current Assets | 11.4M | 17.5M | 53.1M | 31.5M | 27.7M | 20.6M | |
Other Stockholder Equity | 1.2B | 1.9B | 1.7B | 1.7B | 2.3B | 1.3B | |
Total Liab | 114.5M | 916.2M | 1.6B | 1.5B | 1.6B | 1.7B | |
Property Plant And Equipment Gross | 72.8M | 100.1M | 313.9M | 341.9M | 430.0M | 451.5M | |
Total Current Assets | 597.4M | 1.9B | 1.1B | 1.2B | 1.3B | 956.1M | |
Accumulated Other Comprehensive Income | 1.1M | 2.7M | (4.8M) | (19.5M) | (3.7M) | (3.9M) | |
Non Current Liabilities Other | 8.6M | 43.1M | 3.9M | 9.2M | 96.0M | 100.8M | |
Short Term Debt | 7.1M | 6.6M | 12.9M | 21.9M | 28.0M | 29.3M | |
Property Plant Equipment | 72.8M | 62.8M | 313.9M | 167.9M | 193.1M | 106.4M | |
Net Invested Capital | 798.4M | 2.1B | 1.8B | 1.2B | 1.3B | 1.2B | |
Net Working Capital | 524.6M | 1.8B | 919.4M | 998.4M | 1.1B | 950.8M | |
Intangible Assets | 15.4M | 16.2M | 14.2M | 11.7M | 9.0M | 13.1M |
Guardant Health Investors Sentiment
The influence of Guardant Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Guardant. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Guardant Health's public news can be used to forecast risks associated with an investment in Guardant. The trend in average sentiment can be used to explain how an investor holding Guardant can time the market purely based on public headlines and social activities around Guardant Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Guardant Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Guardant Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Guardant Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Guardant Health.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Guardant Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Guardant Health's short interest history, or implied volatility extrapolated from Guardant Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Guardant Stock analysis
When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.036 | Quarterly Revenue Growth 0.222 | Return On Assets (0.18) | Return On Equity (4.38) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.